NCT06273748 RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
| NCT ID | NCT06273748 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meyer Children's Hospital IRCCS |
| Condition | Uveitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 290 participants |
| Start Date | 2022-02-10 |
| Primary Completion | 2032-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 290 participants in total. It began in 2022-02-10 with a primary completion date of 2032-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Uveitis is an inflammatory disease of the uvea, one of the highly vascularized fundamental structures of the eye. It is a rare condition in children, with an incidence in the pediatric population ranging from 2% to 14% of all uveitis cases. The diagnosis and management of patients with uveitis rely on a multidisciplinary approach involving an ophthalmologist, a rheumatologist, and an infectious disease specialist to establish the correct diagnosis and assess the involvement of other organs. In Italy, there is no national or regional registry for non-infectious chronic uveitis as per the Prime Ministerial Decree (DPCM) of March 3, 2017 (Identification of surveillance systems and registries for mortality, tumors, and other diseases). However, many clinical centers adopt data recording systems to evaluate the quality of care and to study diseases and outcomes. The Universitary Hospital Meyer Institute Research Hospital (IRCCS) is a national referral center for managing these pediatric cases of non-infectious chronic uveitis, estimated to constitute 95% of all pediatric uveitis cases
Eligibility Criteria
Inclusion Criteria: * diagnosis of non-infectious chronic uveitis before the age of 16; * signed informed consent form. Exclusion Criteria: * Patients with a diagnosis of infectious uveitis * history of malignant pathology, * history of demyelinating pathology, * history of cerebral vasculitis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06273748 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 16 Years, studying Uveitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06273748 currently recruiting?
Yes, NCT06273748 is actively recruiting participants. Contact the research team at gabriele.simonini@meyer.it for enrollment information.
Where is the NCT06273748 trial being conducted?
This trial is being conducted at Kansas City, United States, Boston, United States, Cincinnati, United States, Ghent, Belgium and 11 additional locations.
Who is sponsoring the NCT06273748 clinical trial?
NCT06273748 is sponsored by Meyer Children's Hospital IRCCS. The trial plans to enroll 290 participants.